Savannah, GA - An open-label, randomized trial has shown that 10 mg of rosuvastatin (Crestor, AstraZeneca) significantly reduced high-sensitivity C-reactive protein (hs-CRP) levels in a group of ...
Large observational studies, small prospective studies and post-hoc analyses of randomised clinical trials have suggested that statins could be beneficial in patients with chronic heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback